{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:19:27Z","timestamp":1778163567207,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00018-022-04129-0","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T06:02:58Z","timestamp":1645164178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["METTL3 promotes oxaliplatin resistance of gastric cancer CD133+\u2009stem cells by promoting PARP1 mRNA stability"],"prefix":"10.1007","volume":"79","author":[{"given":"Huafu","family":"Li","sequence":"first","affiliation":[]},{"given":"Chunming","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Linxiang","family":"Lan","sequence":"additional","affiliation":[]},{"given":"Leping","family":"Yan","sequence":"additional","affiliation":[]},{"given":"Wuguo","family":"Li","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Evans","sequence":"additional","affiliation":[]},{"given":"E. Josue","family":"Ruiz","sequence":"additional","affiliation":[]},{"given":"Qiao","family":"Su","sequence":"additional","affiliation":[]},{"given":"Guangying","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Wenhui","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Haiyong","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Zhijun","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Zhenran","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Joaquim M.","family":"Oliveira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-2710","authenticated-orcid":false,"given":"Axel","family":"Behrens","sequence":"additional","affiliation":[]},{"given":"Rui L.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Changhua","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"issue":"9","key":"4129_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I (2020) Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 69(9):1564\u20131571","journal-title":"Gut"},{"issue":"10060","key":"4129_CR2","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/S0140-6736(16)32226-7","volume":"388","author":"L Zong","year":"2016","unstructured":"Zong L, Abe M, Seto Y, Ji J (2016) The challenge of screening for early gastric cancer in China. Lancet (London, England) 388(10060):2606","journal-title":"Lancet (London, England)"},{"issue":"2","key":"4129_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/annonc\/mdy540","volume":"30","author":"N Boku","year":"2019","unstructured":"Boku N, Ryu MH, Kato K, Chung HC, Minashi K, Lee KW et al (2019) Safety and efficacy of nivolumab in combination with S-1\/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric\/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4). Ann Oncol Off J Eur Soc Med Oncol 30(2):250\u2013258","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"4129_CR4","doi-asserted-by":"crossref","unstructured":"Harada K, Sakamoto N, Ukai S, Yamamoto Y, Pham QT, Taniyama D, et al. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance. Gastric Cancer 2021.","DOI":"10.1007\/s10120-021-01206-4"},{"issue":"11","key":"4129_CR5","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41556-019-0407-1","volume":"21","author":"VM Wang","year":"2019","unstructured":"Wang VM, Ferreira RMM, Almagro J, Evan T, Legrave N, Zaw Thin M et al (2019) CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. Nat Cell Biol 21(11):1425\u20131435","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4129_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","volume":"16","author":"V Plaks","year":"2015","unstructured":"Plaks V, Kong N, Werb Z (2015) The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 16(3):225\u2013238","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4129_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2015.08.005","volume":"369","author":"M Xu","year":"2015","unstructured":"Xu M, Gong A, Yang H, George SK, Jiao Z, Huang H et al (2015) Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)\/Musashi-1(+) gastric cancer stem cells. Cancer Lett 369(1):124\u2013133","journal-title":"Cancer Lett"},{"issue":"5","key":"4129_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/stem.30","volume":"27","author":"S Takaishi","year":"2009","unstructured":"Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R et al (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells (Dayton, Ohio) 27(5):1006\u20131020","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"23","key":"4129_CR9","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1158\/1078-0432.CCR-13-0742","volume":"19","author":"S Yano","year":"2013","unstructured":"Yano S, Tazawa H, Hashimoto Y, Shirakawa Y, Kuroda S, Nishizaki M et al (2013) A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S\/G2\/M phases. Clin Cancer Res Off J Am Assoc Cancer Res 19(23):6495\u20136505","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"4129_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semcancer.2018.11.006","volume":"53","author":"TB Steinbichler","year":"2018","unstructured":"Steinbichler TB, Dud\u00e1s J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II (2018) Therapy resistance mediated by cancer stem cells. Semin Cancer Biol 53:156\u2013167","journal-title":"Semin Cancer Biol"},{"key":"4129_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ctrv.2018.07.004","volume":"69","author":"X Bai","year":"2018","unstructured":"Bai X, Ni J, Beretov J, Graham P, Li Y (2018) Cancer stem cell in breast cancer therapeutic resistance. Cancer Treat Rev 69:152\u2013163","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4129_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-017-0624-9","volume":"16","author":"P Zhou","year":"2017","unstructured":"Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu Y et al (2017) The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer 16(1):52","journal-title":"Mol Cancer"},{"issue":"5","key":"4129_CR13","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/hep.30404","volume":"69","author":"L Huang","year":"2019","unstructured":"Huang L, Cai J, Guo H, Gu J, Tong Y, Qiu B et al (2019) ID3 promotes stem cell features and predicts chemotherapeutic response of intrahepatic cholangiocarcinoma. Hepatol (Baltimore, MD) 69(5):1995\u20132012","journal-title":"Hepatol (Baltimore, MD)"},{"issue":"5","key":"4129_CR14","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1158\/1078-0432.CCR-17-2575","volume":"24","author":"A Lucena-Cacace","year":"2018","unstructured":"Lucena-Cacace A, Otero-Albiol D, Jim\u00e9nez-Garc\u00eda MP, Mu\u00f1oz-Galvan S, Carnero A (2018) NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through Sirt1 and PARP. Clin Cancer Res Off J Am Assoc Cancer Res 24(5):1202\u20131215","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"4129_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-018-0562-z","volume":"11","author":"SJ Ni","year":"2018","unstructured":"Ni SJ, Zhao LQ, Wang XF, Wu ZH, Hua RX, Wan CH et al (2018) CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-\u03baB-miR-21 pathways. J Hematol Oncol 11(1):17","journal-title":"J Hematol Oncol"},{"issue":"7120","key":"4129_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756\u2013760","journal-title":"Nature"},{"issue":"3","key":"4129_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2017.04.006","volume":"66","author":"I Vitale","year":"2017","unstructured":"Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L (2017) DNA damage in stem cells. Mol Cell 66(3):306\u2013319","journal-title":"Mol Cell"},{"issue":"7849","key":"4129_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-020-03135-1","volume":"591","author":"T Chelmicki","year":"2021","unstructured":"Chelmicki T, Roger E, Teissandier A, Dura M, Bonneville L, Rucli S et al (2021) m(6)A RNA methylation regulates the fate of endogenous retroviruses. Nature 591(7849):312\u2013316","journal-title":"Nature"},{"issue":"4","key":"4129_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V et al (2018) Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance. Oncogene 37(4):522\u2013533","journal-title":"Oncogene"},{"issue":"2","key":"4129_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L et al (2018) METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell 22(2):191-205.e199","journal-title":"Cell Stem Cell"},{"key":"4129_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fonc.2019.00332","volume":"9","author":"Y Bai","year":"2019","unstructured":"Bai Y, Yang C, Wu R, Huang L, Song S, Li W et al (2019) YTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinoma. Front Oncol 9:332","journal-title":"Front Oncol"},{"issue":"23","key":"4129_CR22","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","volume":"39","author":"C Zhang","year":"2020","unstructured":"Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K et al (2020) YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene 39(23):4507\u20134518","journal-title":"Oncogene"},{"issue":"2","key":"4129_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","volume":"11","author":"D Dixit","year":"2021","unstructured":"Dixit D, Prager BC, Gimple RC, Poh HX, Wang Y, Wu Q et al (2021) The RNA m6A Reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells. Cancer Discov 11(2):480\u2013499","journal-title":"Cancer Discov"},{"issue":"1","key":"4129_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-019-0830-6","volume":"12","author":"D Jin","year":"2019","unstructured":"Jin D, Guo J, Wu Y, Du J, Yang L, Wang X et al (2019) m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol 12(1):135","journal-title":"J Hematol Oncol"},{"issue":"12","key":"4129_CR25","doi-asserted-by":"publisher","first-page":"e103181","DOI":"10.15252\/embj.2019103181","volume":"39","author":"Z Lin","year":"2020","unstructured":"Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X et al (2020) RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J 39(12):e103181","journal-title":"EMBO J"},{"issue":"12","key":"4129_CR26","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.ymthe.2020.09.007","volume":"28","author":"X Liu","year":"2020","unstructured":"Liu X, Gonzalez G, Dai X, Miao W, Yuan J, Huang M et al (2020) Adenylate kinase 4 modulates the resistance of breast cancer cells to tamoxifen through an m6A-based epitranscriptomic mechanism. Mol Ther 28(12):2593\u20132604","journal-title":"Mol Ther"},{"issue":"2","key":"4129_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/gutjnl-2017-314549","volume":"68","author":"T Seidlitz","year":"2019","unstructured":"Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Gr\u00fctzmann K et al (2019) Human gastric cancer modelling using organoids. Gut 68(2):207\u2013217","journal-title":"Gut"},{"issue":"1","key":"4129_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L et al (2019) RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18(1):46","journal-title":"Mol Cancer"},{"issue":"2","key":"4129_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1084\/jem.20180742","volume":"216","author":"EJ Ruiz","year":"2019","unstructured":"Ruiz EJ, Diefenbacher ME, Nelson JK, Sancho R, Pucci F, Chakraborty A et al (2019) LUBAC determines chemotherapy resistance in squamous cell lung cancer. J Exp Med 216(2):450\u2013465","journal-title":"J Exp Med"},{"issue":"2","key":"4129_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN et al (2018) Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173(2):338-354.e315","journal-title":"Cell"},{"key":"4129_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf 12:323","journal-title":"BMC Bioinf"},{"issue":"18","key":"4129_CR32","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","volume":"28","author":"B Snel","year":"2000","unstructured":"Snel B, Lehmann G, Bork P, Huynen MA (2000) STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 28(18):3442\u20133444","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4129_CR33","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M et al (2015) Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161(5):1202\u20131214","journal-title":"Cell"},{"issue":"14","key":"4129_CR34","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1093\/bioinformatics\/btaa532","volume":"36","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Y, Hu J, Zhang J, Guo F, Zhou M et al (2020) scTPA: a web tool for single-cell transcriptome analysis of pathway activation signatures. Bioinf (Oxf, Engl) 36(14):4217\u20134219","journal-title":"Bioinf (Oxf, Engl)"},{"issue":"10184","key":"4129_CR35","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet (Lond, Engl) 393(10184):1948\u20131957","journal-title":"Lancet (Lond, Engl)"},{"issue":"1","key":"4129_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-019-0981-7","volume":"18","author":"T Liu","year":"2019","unstructured":"Liu T, Zhang X, Du L, Wang Y, Liu X, Tian H et al (2019) Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer 18(1):43","journal-title":"Mol Cancer"},{"issue":"10","key":"4129_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14(10):611\u2013629","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"4129_CR38","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/1535-7163.MCT-14-0636","volume":"14","author":"E Martinez-Balibrea","year":"2015","unstructured":"Martinez-Balibrea E, Mart\u00ednez-Card\u00fas A, Gin\u00e9s A, Ruizorras V, Moutinho C, Layos L et al (2015) Tumor-related molecular mechanisms of oxaliplatin resistance. Mol Cancer Ther 14(8):1767\u20131776","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"4129_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13046-019-1405-7","volume":"38","author":"SY Park","year":"2019","unstructured":"Park SY, Lee CJ, Choi JH, Kim JH, Kim JW, Kim JY et al (2019) The JAK2\/STAT3\/CCND2 axis promotes colorectal cancer stem cell persistence and radioresistance. J Exp Clin Cancer Res CR 38(1):399","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"10","key":"4129_CR40","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.tcb.2019.07.008","volume":"29","author":"SM Noordermeer","year":"2019","unstructured":"Noordermeer SM, van Attikum H (2019) PARP inhibitor resistance: a tug-of-war in BRCA-mutated cells. Trends Cell Biol 29(10):820\u2013834","journal-title":"Trends Cell Biol"},{"issue":"33","key":"4129_CR41","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1126\/sciadv.abf3641","volume":"7","author":"NAW Bell","year":"2021","unstructured":"Bell NAW, Haynes PJ, Brunner K, de Oliveira TM, Flocco MM, Hoogenboom BW et al (2021) Single-molecule measurements reveal that PARP1 condenses DNA by loop stabilization. Sci Adv 7(33):3641","journal-title":"Sci Adv"},{"key":"4129_CR42","doi-asserted-by":"crossref","unstructured":"Singh MP, Cho HJ, Kim JT, Baek KE, Lee HG, Kang SC (2019) Morin hydrate reverses cisplatin resistance by impairing PARP1\/HMGB1-dependent autophagy in hepatocellular carcinoma. Cancers 11(7)","DOI":"10.3390\/cancers11070986"},{"key":"4129_CR43","doi-asserted-by":"crossref","unstructured":"Hu K, Wu W, Li Y, Lin L, Chen D, Yan H et al (2019) Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. EMBO Rep 20(5)","DOI":"10.15252\/embr.201846166"},{"issue":"7","key":"4129_CR44","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1111\/jcmm.15058","volume":"24","author":"M Avitabile","year":"2020","unstructured":"Avitabile M, Lasorsa VA, Cantalupo S, Cardinale A, Cimmino F, Montella A et al (2020) Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma. J Cell Mol Med 24(7):4072\u20134081","journal-title":"J Cell Mol Med"},{"issue":"18","key":"4129_CR45","doi-asserted-by":"publisher","first-page":"9537","DOI":"10.1093\/nar\/gky764","volume":"46","author":"J Slyskova","year":"2018","unstructured":"Slyskova J, Sabatella M, Ribeiro-Silva C, Stok C, Theil AF, Vermeulen W et al (2018) Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage. Nucleic Acids Res 46(18):9537\u20139549","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4129_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41467-018-03159-2","volume":"9","author":"GE Ronson","year":"2018","unstructured":"Ronson GE, Piberger AL, Higgs MR, Olsen AL, Stewart GS, McHugh PJ et al (2018) PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation. Nat Commun 9(1):746","journal-title":"Nat Commun"},{"issue":"8","key":"4129_CR47","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1093\/nar\/gkv250","volume":"43","author":"P Reynolds","year":"2015","unstructured":"Reynolds P, Cooper S, Lomax M, O\u2019Neill P (2015) Disruption of PARP1 function inhibits base excision repair of a sub-set of DNA lesions. Nucleic Acids Res 43(8):4028\u20134038","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"4129_CR48","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T (2019) The critical role of RNA m(6)A methylation in cancer. Can Res 79(7):1285\u20131292","journal-title":"Can Res"},{"issue":"1","key":"4129_CR49","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41467-019-09712-x","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Bai R, Li M, Ye H, Wu C, Wang C et al (2019) Excessive miR-25-3p maturation via N(6)-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nat Commun 10(1):1858","journal-title":"Nat Commun"},{"issue":"1","key":"4129_CR50","doi-asserted-by":"publisher","first-page":"118878","DOI":"10.1016\/j.bbamcr.2020.118878","volume":"1868","author":"L Hao","year":"2021","unstructured":"Hao L, Wang JM, Liu BQ, Yan J, Li C, Jiang JY et al (2021) m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Biochim Et Biophys Acta Mol Cell Res 1868(1):118878","journal-title":"Biochim Et Biophys Acta Mol Cell Res"},{"key":"4129_CR51","doi-asserted-by":"publisher","first-page":"630260","DOI":"10.3389\/fonc.2021.630260","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Meng Q, Ma B (2021) Characterization of the prognostic m6A-Related lncRNA signature in gastric cancer. Front Oncol 11:630260","journal-title":"Front Oncol"},{"issue":"11","key":"4129_CR52","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.drudis.2021.06.004","volume":"26","author":"S Garbo","year":"2021","unstructured":"Garbo S, Zwergel C, Battistelli C (2021) m6A RNA methylation and beyond\u2014the epigenetic machinery and potential treatment options. Drug Discov Today 26(11):2559\u20132574","journal-title":"Drug Discov Today"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04129-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04129-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04129-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T20:11:41Z","timestamp":1666728701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04129-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4129"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04129-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (Ethical Review [2018] No. 087). And the clinical research and animal experiment ethics committee of the First Affiliated Hospital of Sun Yat-sen University (Ethical Review [2017] No. 208).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We understand that journals may be available in both print and on the internet, and will be available to a broader audience through marketing channels and other third parties. I understand that readers may include not only medical professionals and scholarly researchers but also journalists and general members of the public.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"135"}}